Over one third of all deaths in Kenya in 2019 were attributed to NCDs (Vos et al., 2020). The four major NCDs – CVDs, cancer, diabetes and chronic respiratory diseases – accounted for 57% of these deaths. Furthermore, the direct and indirect economic impact of NCDs is significant- Kenya is said to have lost Ksh 230 billion or 3.4% of its gross domestic product in 2016 from rising NCD-related medical costs and indirect productivity losses. At the household level, an estimated decrease of 28.6% in income due to NCDs was reported in 2007 (Mwai & Muriithi, 2016; Mensah et al., 2020). Therefore, preventing and managing NCDs are significant public health and economic priorities.